Research ArticleCancer

A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer

See allHide authors and affiliations

Science Translational Medicine  23 Jan 2019:
Vol. 11, Issue 476, eaav1620
DOI: 10.1126/scitranslmed.aav1620

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article